Resumen
Background. We examined frailty as a predictor of recovery in older adults hospitalized with influenza and acute respiratory illness. Methods. A total of 5011 patients aged ≥65 years were admitted to Canadian Serious Outcomes Surveillance Network hospitals during the 2011/2012, 2012/2013, and 2013/2014 influenza seasons. Frailty was measured using a previously validated frailty index (FI). Poor recovery was defined as death by 30 days postdischarge or an increase of more than 0.06 (≥2 persistent new health deficits) on the FI. Multivariable logistic regression controlled for age, sex, season, influenza diagnosis, and influenza vaccination status. Results. Mean age was 79.4 (standard deviation = 8.4) years; 53.1% were women. At baseline, 15.0% (n = 750) were nonfrail, 39.3% (n = 1971) were prefrail, 39.8% (n = 1995) were frail, and 5.9% (n = 295) were most frail. Poor recovery was experienced by 21.4%, 52.0% of whom had died. Frailty was associated with lower odds of recovery in all 3 seasons: 2011/2012 (odds ratio [OR] = 0.70; 95% confidence interval [CI], 0.59-0.84), 2012/2013 (OR = 0.72; 95% CI, 0.66-0.79), and 2013/2014 (OR = 0.75; 95% CI, 0.69-0.82); results varied by season, influenza status, vaccination status, and age. Conclusions. Increasing frailty is associated with lower odds of recovery, and persistent worsening frailty is an important adverse outcome of acute illness.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 428-437 |
Número de páginas | 10 |
Publicación | Journal of Infectious Diseases |
Volumen | 222 |
N.º | 3 |
DOI | |
Estado | Published - ago. 1 2020 |
Nota bibliográfica
Funding Information:Funding for this study was provided by the Public Health Agency of Canada and the Canadian Institutes of Health Research to the Canadian Immunization Research Network (CIRN) and through an investigator-initiated Collaborative Research Agreement with GlaxoSmithKline Biologicals SA.
Publisher Copyright:
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
ASJC Scopus Subject Areas
- Immunology and Allergy
- Infectious Diseases